However, in contrast to breast cancer cells, Slit2N did not have any effect on the downregulation of either CXCR4/CCR5 or CD4 expression, ruling out down-modulation of HIV-1 receptors/co-receptors as a mechanism of action for Slit2. Here, CD4 is linked to breast carcinoma.